Rare Neurological Disease Treatment Market Overview
The rare neurological disease treatment market covers therapies for conditions like Batten disease, Rett syndrome, and Dravet syndrome. These disorders, though individually rare, collectively affect millions globally and pose major therapeutic challenges.
Market Overview
Growing attention to rare diseases has spurred drug discovery in neurology, a field once considered intractable. Orphan drug frameworks and patient advocacy are accelerating the development of effective treatments.
Market Drivers
Increasing research funding: Governments and non-profits are boosting R&D in rare neurological disorders.
Emergence of gene-based therapies: CRISPR and antisense technologies are showing clinical promise.
41 Views